Indivior (NASDAQ:INDV) executives told investors the company’s 2025 performance reflected a “transition year” marked by ...

Generated Record Quarterly and Full-Year Total SUBLOCADE® Net Revenue of $252 Million and $856 MillionAchieved Quarterly and Full-Year GAAP Net ...

Q4 2025 Management View CEO Joseph Ciaffoni stated that 2025 was a transition year, highlighting the successful completion of Phase I Generate Momentum and the delivery of record net revenue for ...

Thanks, Jason, good morning and thank you for joining us on today's call to review our fourth quarter and full year 2025 results. Last July, we rolled out the Indivior Action Agenda to maximize the ...

Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...

Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences: Joe Ciaffoni, Chief Executive Officer, will host 1x1 / group ...

Indivior has picked Havas as its primary partner for engaging healthcare professionals and patients in the U.S.  | Havas will lead Indivior’s integrated strategy, creative, media and digital efforts ...

With a $385 million settlement, Suboxone maker Indivior is moving to wrap up years of antitrust litigation tied to its opioid addiction treatment. The company will shell out the money to resolve ...

Havas will lead integrated strategy, creative media, and digital efforts across healthcare professional and direct-to-consumer audiences for the Virginia-based drugmaker.

ALBANY - More than a year after the office of New York Attorney General Letitia James reached an $86 million settlement with drugmaker Indivior over its alleged role in fueling the state's opioid ...

Starting a GLP-1 drug was linked with a 14% overall reduced risk of new substance use disorders and a lower risk of harm for ...

Indivior Pharmaceuticals, Inc. ( INDV) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Good morning, everyone. I am joined today by Joe Ciaffoni, Chief Executive Officer; Pat Barry, Chief ...